Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor–positive early breast cancer patients

被引:0
|
作者
Johanna G. H. van Nes
Esther M. de Kruijf
Hein Putter
Dana Faratian
Alison Munro
Fiona Campbell
Vincent T. H. B. M. Smit
Gerrit-Jan Liefers
Peter J. K. Kuppen
Cornelis J. H. van de Velde
John M. S. Bartlett
机构
[1] Leiden University Medical Centre,Department of Surgery
[2] University Medical Centre Groningen,Department of Radiation Oncology
[3] University of Groningen,Department of Medical Statistics
[4] Leiden University Medical Centre,Department of Pathology, Endocrine Cancer Group, Edinburgh Cancer Research Centre
[5] Western General Hospital,Department of Pathology
[6] Leiden University Medical Centre,undefined
来源
Breast Cancer Research and Treatment | 2012年 / 133卷
关键词
Early breast cancer; Prognostic factors; SNAIL; SLUG; TWIST;
D O I
暂无
中图分类号
学科分类号
摘要
Epithelial mesenchymal transition (EMT) plays an important role in the development of metastases. One of the hallmarks of EMT is loss of E-cadherin and gain of N-cadherin expression, which are regulated by transcription factors, such as SNAIL, SLUG, and TWIST. We examined the prognostic value of these factors as well as E-cadherin and N-cadherin, in a well-described large cohort of breast cancer patients treated with primary surgery. Analyses were stratified by estrogen receptor (ER) status, because of its crucial role in the regulation of these transcription factors. SNAIL, SLUG, and TWIST expression were examined on a TMA containing 575 breast tumors using immunohistochemistry. Nuclear expression was quantified using a weighted histoscore and classified as high versus low expression, based on the median histoscore. High expression of SNAIL, SLUG, and TWIST was seen in 54, 50, and 50% of tumors, respectively. The level of SNAIL (P = 0.014) and TWIST (P = 0.006) expression was associated with a worse patient relapse-free period, specifically in patients with ER-positive tumors (interaction Cox proportional hazards P = 0.039). Combining both factors resulted in an independent prognostic factor with high discriminative power (both low versus either high: HR 1.15; both low versus both high HR 1.84; P = 0.010). Co-expression of SNAIL–TWIST was associated with low-E-cadherin and high-N-cadherin expression, especially in ER-positive tumors (P = 0.009), suggesting that, through interactions with ER, SNAIL and TWIST may regulate E- and N-cadherin expression, thereby inducing EMT. Our results are indicative that SNAIL and TWIST play a crucial role in EMT through regulation of E- and N-cadherin expression, exclusively in ER-positive breast cancer patients.
引用
收藏
页码:49 / 59
页数:10
相关论文
共 50 条
  • [21] Androgen receptor in estrogen receptor positive breast cancer: Beyond expression
    Basile, Debora
    Cinausero, Marika
    Iacono, Donatella
    Pelizzari, Giacomo
    Bonotto, Marta
    Vitale, Maria Grazia
    Gerratana, Lorenzo
    Puglisi, Fabio
    CANCER TREATMENT REVIEWS, 2017, 61 : 15 - 22
  • [22] MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancer
    Watanabe, Manabu
    Shibata, Masahiro
    Inaishi, Takahiro
    Ichikawa, Takahiro
    Soeda, Ikumi
    Miyajima, Noriyuki
    Takano, Yuko
    Takeuchi, Dai
    Tsunoda, Nobuyuki
    Kanda, Mitsuro
    Kikumori, Toyone
    Kodera, Yasuhiro
    Nagino, Masato
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [23] The prognostic impact of synaptojanin 2 expression in estrogen receptor α-positive breast cancer patients
    Nishikawa, S.
    Kondo, N.
    Wanifuchi-Endo, Y.
    Hisada, T.
    Uemoto, Y.
    Katagiri, Y.
    Dong, Y.
    Kato, H.
    Takahashi, S.
    Toyama, T.
    CANCER RESEARCH, 2019, 79 (04)
  • [24] High Expression of LMTK3 is an Independent Factor Indicating a Poor Prognosis in Estrogen Receptor α-Positive Breast Cancer Patients
    Asano, Tomoko
    Sato, Shinya
    Yoshimoto, Nobuyasu
    Endo, Yumi
    Hato, Yukari
    Dong, Yu
    Takahashi, Satoru
    Fujii, Yoshitaka
    Toyama, Tatsuya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (10) : 889 - 897
  • [25] CD73 expression regulated by estrogen signaling associates with poor prognosis in estrogen receptor (ER)-positive breast cancer
    Katsuta, E.
    Anand, V.
    Yan, L.
    Dasgupta, S.
    Takabe, K.
    CANCER RESEARCH, 2019, 79 (04)
  • [26] FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
    Nelson Rangel
    Nicoletta Fortunati
    Simona Osella-Abate
    Laura Annaratone
    Claudio Isella
    Maria Graziella Catalano
    Letizia Rinella
    Jasna Metovic
    Renzo Boldorini
    Davide Balmativola
    Pietro Ferrando
    Francesca Marano
    Paola Cassoni
    Anna Sapino
    Isabella Castellano
    BMC Cancer, 18
  • [27] FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients
    Rangel, Nelson
    Fortunati, Nicoletta
    Osella-Abate, Simona
    Annaratone, Laura
    Isella, Claudio
    Catalano, Maria Graziella
    Rinella, Letizia
    Metovic, Jasna
    Boldorini, Renzo
    Balmativola, Davide
    Ferrando, Pietro
    Marano, Francesca
    Cassoni, Paola
    Sapino, Anna
    Castellano, Isabella
    BMC CANCER, 2018, 18
  • [28] Impact of estrogen receptor (ER) and HER2 co-expression on breast cancer characteristics and disease presentation
    Al-Qaisi, A.
    Chen, L.
    Romond, E.
    Stevens, M.
    Pasley, G.
    Massarweh, S.
    CANCER RESEARCH, 2013, 73
  • [29] The Clinical Characteristics of HER2 Positive Early Breast Cancer with Basal Marker Co-Expression
    Park, S.
    Shin, Y. K.
    Cho, E. Y.
    Hong, S. H.
    Choi, Y-L.
    CANCER RESEARCH, 2010, 70
  • [30] Co-expression of HER3 in HER2-positive metastatic breast cancer patients is an independent predictor of impaired prognosis
    Berghoff, A. S.
    Bago-Horvath, Z.
    Preusser, M.
    Steger, G. G.
    Rudas, M.
    Birner, P.
    Zielinski, C. C.
    Bartsch, R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S421 - S421